Pharmascience Canada idakhazikitsa mankhwala ake atsopano a generic pms-LURASIDONE pamsika waku Canada ndipo azipezeka pamtengo wotsika kwa odwala.
Pms-LURASIDONE ikuwonetsedwa ngati monotherapy pakuwongolera mawonetseredwe a schizophrenia mwa akulu ndi achinyamata (wazaka 15-17). Imawonetsedwanso pakuwongolera kwakanthawi kwamagawo okhumudwa omwe amakhudzana ndi matenda a bipolar mwa akulu ndi achinyamata (wazaka 13-17). Ngakhale pms-LURASIDONE sichingachiritse izi, zitha kuthandiza kuthana ndi zizindikiro.
Mankhwalawa, omwe ali m'gulu lamankhwala otchedwa atypical antipsychotics, adzagawidwa mu mphamvu zingapo, monga 20 mg, 40 mg, 60 mg, 80 mg ndi 120 mg.
Kupereka mbiri yofanana yachitetezo komanso yogwira ntchito ngati mankhwala amtundu, mapiritsi awa a pms-LURASIDONE ndi ofanana ndi Latuda ®.
ZOMWE MUNGACHITE PA NKHANIYI:
- Pms-LURASIDONE is indicated as monotherapy for the management of the manifestations of schizophrenia in adults and in adolescents (15-17 years of age).
- Kupereka mbiri yofanana yachitetezo komanso yogwira ntchito ngati mankhwala amtundu, mapiritsi awa a pms-LURASIDONE ndi ofanana ndi Latuda ®.
- It is also indicated for the acute management of depressive episodes associated with bipolar disorder in adults and adolescents (13-17 years of age).
